 Fabienne Gally
Concepts (186)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fatty Acid-Binding Proteins | 6 | 2023 | 60 | 2.460 |
Why?
| | TRPM Cation Channels | 2 | 2018 | 67 | 1.160 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 3 | 2023 | 916 | 1.070 |
Why?
| | Smoke | 3 | 2017 | 123 | 0.990 |
Why?
| | Pneumonia, Mycoplasma | 4 | 2012 | 30 | 0.950 |
Why?
| | PPAR gamma | 3 | 2022 | 182 | 0.930 |
Why?
| | Mycoplasma pneumoniae | 3 | 2012 | 28 | 0.870 |
Why?
| | Neoplasm Proteins | 2 | 2019 | 385 | 0.870 |
Why?
| | Listeriosis | 2 | 2019 | 61 | 0.770 |
Why?
| | Immunity, Innate | 6 | 2017 | 723 | 0.760 |
Why?
| | Listeria monocytogenes | 2 | 2019 | 111 | 0.740 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2023 | 1892 | 0.720 |
Why?
| | Mucin-5B | 2 | 2022 | 183 | 0.690 |
Why?
| | Radiodermatitis | 1 | 2018 | 7 | 0.640 |
Why?
| | Macrophages | 3 | 2022 | 1261 | 0.640 |
Why?
| | Idiopathic Pulmonary Fibrosis | 2 | 2022 | 505 | 0.610 |
Why?
| | Inflammation | 5 | 2023 | 2481 | 0.590 |
Why?
| | Macrophages, Alveolar | 3 | 2021 | 347 | 0.580 |
Why?
| | Glycoproteins | 3 | 2021 | 304 | 0.570 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2017 | 144 | 0.550 |
Why?
| | Cytokines | 4 | 2019 | 1843 | 0.540 |
Why?
| | Pneumonia | 3 | 2021 | 566 | 0.480 |
Why?
| | Lung | 8 | 2023 | 3546 | 0.460 |
Why?
| | Down Syndrome | 1 | 2017 | 338 | 0.410 |
Why?
| | Phosphoproteins | 2 | 2011 | 299 | 0.400 |
Why?
| | Epithelial Cells | 3 | 2017 | 955 | 0.390 |
Why?
| | Mice | 17 | 2023 | 14916 | 0.390 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2013 | 139 | 0.390 |
Why?
| | Mice, Knockout | 6 | 2021 | 2582 | 0.390 |
Why?
| | Bronchi | 1 | 2013 | 232 | 0.380 |
Why?
| | Pseudomonas aeruginosa | 2 | 2013 | 298 | 0.380 |
Why?
| | Pseudomonas Infections | 1 | 2013 | 184 | 0.380 |
Why?
| | Down-Regulation | 1 | 2013 | 596 | 0.360 |
Why?
| | Mice, Inbred C57BL | 7 | 2018 | 4710 | 0.330 |
Why?
| | ADP-ribosyl Cyclase 1 | 1 | 2008 | 35 | 0.320 |
Why?
| | Respiratory Hypersensitivity | 1 | 2008 | 60 | 0.310 |
Why?
| | Influenza, Human | 1 | 2013 | 545 | 0.290 |
Why?
| | Oxidative Stress | 1 | 2013 | 1084 | 0.280 |
Why?
| | Toll-Like Receptor 2 | 3 | 2013 | 109 | 0.280 |
Why?
| | Animals | 18 | 2023 | 31761 | 0.280 |
Why?
| | Cells, Cultured | 7 | 2019 | 3890 | 0.270 |
Why?
| | Bacterial Load | 2 | 2019 | 58 | 0.270 |
Why?
| | Binding Sites | 2 | 2021 | 1176 | 0.260 |
Why?
| | RNA, Messenger | 3 | 2019 | 2557 | 0.250 |
Why?
| | Allergens | 1 | 2008 | 413 | 0.250 |
Why?
| | DNA-Binding Proteins | 1 | 2011 | 1314 | 0.240 |
Why?
| | Chemokine CX3CL1 | 1 | 2023 | 20 | 0.220 |
Why?
| | Transcription Factors | 1 | 2011 | 1528 | 0.220 |
Why?
| | Cell Line | 2 | 2021 | 2639 | 0.220 |
Why?
| | Gene Expression Regulation | 3 | 2022 | 2321 | 0.220 |
Why?
| | Enhancer Elements, Genetic | 2 | 2021 | 152 | 0.210 |
Why?
| | Superoxide Dismutase | 2 | 2015 | 305 | 0.210 |
Why?
| | Niemann-Pick Disease, Type A | 1 | 2021 | 4 | 0.190 |
Why?
| | Niemann-Pick Disease, Type B | 1 | 2021 | 4 | 0.190 |
Why?
| | Lysophospholipase | 1 | 2021 | 10 | 0.190 |
Why?
| | Sphingomyelin Phosphodiesterase | 1 | 2021 | 21 | 0.190 |
Why?
| | Lipopolysaccharides | 3 | 2023 | 812 | 0.190 |
Why?
| | NF-kappa B | 3 | 2019 | 636 | 0.190 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2023 | 359 | 0.190 |
Why?
| | A549 Cells | 1 | 2021 | 51 | 0.180 |
Why?
| | Gain of Function Mutation | 1 | 2021 | 30 | 0.180 |
Why?
| | Proto-Oncogene Proteins c-ets | 1 | 2021 | 51 | 0.180 |
Why?
| | Pulmonary Emphysema | 1 | 2023 | 268 | 0.180 |
Why?
| | Humans | 17 | 2023 | 114709 | 0.180 |
Why?
| | Chromatin | 2 | 2021 | 428 | 0.180 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 928 | 0.170 |
Why?
| | Th2 Cells | 2 | 2012 | 154 | 0.170 |
Why?
| | Respiratory Mucosa | 2 | 2012 | 251 | 0.170 |
Why?
| | Leukocytes, Mononuclear | 1 | 2022 | 493 | 0.170 |
Why?
| | Blotting, Western | 2 | 2013 | 1151 | 0.170 |
Why?
| | STAT3 Transcription Factor | 1 | 2021 | 173 | 0.160 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2018 | 128 | 0.160 |
Why?
| | Alpha-Globulins | 1 | 2018 | 19 | 0.150 |
Why?
| | Disease Models, Animal | 3 | 2021 | 3542 | 0.150 |
Why?
| | Receptors, Glucocorticoid | 1 | 2019 | 130 | 0.150 |
Why?
| | Mice, Transgenic | 5 | 2018 | 1951 | 0.150 |
Why?
| | RNA Polymerase II | 1 | 2021 | 285 | 0.150 |
Why?
| | Models, Genetic | 1 | 2021 | 565 | 0.150 |
Why?
| | Genetic Predisposition to Disease | 3 | 2022 | 2099 | 0.150 |
Why?
| | Dexamethasone | 1 | 2019 | 317 | 0.140 |
Why?
| | Mucociliary Clearance | 2 | 2018 | 41 | 0.140 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2017 | 129 | 0.140 |
Why?
| | Disease Progression | 1 | 2023 | 2384 | 0.140 |
Why?
| | Epigenesis, Genetic | 1 | 2021 | 521 | 0.140 |
Why?
| | Hyaluronic Acid | 1 | 2018 | 188 | 0.130 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2017 | 345 | 0.130 |
Why?
| | Inflammation Mediators | 1 | 2019 | 476 | 0.130 |
Why?
| | Cell Survival | 1 | 2019 | 1021 | 0.130 |
Why?
| | Protein Binding | 2 | 2018 | 1896 | 0.120 |
Why?
| | Reactive Oxygen Species | 1 | 2017 | 536 | 0.120 |
Why?
| | Acute Lung Injury | 1 | 2018 | 298 | 0.120 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2019 | 1134 | 0.120 |
Why?
| | Skin | 1 | 2018 | 659 | 0.120 |
Why?
| | Base Sequence | 1 | 2017 | 2118 | 0.110 |
Why?
| | Immunoprecipitation | 1 | 2013 | 152 | 0.110 |
Why?
| | Lipid Peroxidation | 1 | 2013 | 139 | 0.110 |
Why?
| | Physical Conditioning, Animal | 1 | 2015 | 194 | 0.100 |
Why?
| | Immunoenzyme Techniques | 1 | 2013 | 195 | 0.100 |
Why?
| | Promoter Regions, Genetic | 1 | 2017 | 1133 | 0.100 |
Why?
| | Ovalbumin | 2 | 2012 | 161 | 0.100 |
Why?
| | Risk Factors | 2 | 2023 | 8625 | 0.100 |
Why?
| | Antioxidants | 2 | 2014 | 530 | 0.100 |
Why?
| | Fluorescent Antibody Technique | 1 | 2013 | 396 | 0.100 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 316 | 0.100 |
Why?
| | Heat Shock Transcription Factors | 1 | 2011 | 17 | 0.100 |
Why?
| | Gene Knockdown Techniques | 1 | 2013 | 299 | 0.100 |
Why?
| | Metalloporphyrins | 1 | 2012 | 104 | 0.100 |
Why?
| | Adaptive Immunity | 1 | 2013 | 156 | 0.100 |
Why?
| | Tobacco Products | 1 | 2013 | 98 | 0.100 |
Why?
| | Bronchoalveolar Lavage | 1 | 2011 | 84 | 0.100 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2011 | 61 | 0.100 |
Why?
| | Disease Susceptibility | 1 | 2013 | 316 | 0.090 |
Why?
| | Cartilage, Articular | 1 | 2015 | 289 | 0.090 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 797 | 0.090 |
Why?
| | Toll-Like Receptor 4 | 1 | 2013 | 286 | 0.090 |
Why?
| | Dendritic Cells | 1 | 2012 | 436 | 0.080 |
Why?
| | Chimera | 1 | 2008 | 59 | 0.080 |
Why?
| | Lead | 1 | 2008 | 43 | 0.080 |
Why?
| | Radiation Protection | 1 | 2008 | 34 | 0.080 |
Why?
| | Models, Animal | 1 | 2009 | 345 | 0.070 |
Why?
| | Antibody Formation | 1 | 2008 | 267 | 0.070 |
Why?
| | Bone Marrow | 1 | 2008 | 244 | 0.070 |
Why?
| | Immunoglobulin E | 1 | 2008 | 316 | 0.070 |
Why?
| | Gene Expression | 2 | 2022 | 1420 | 0.070 |
Why?
| | Caenorhabditis elegans | 1 | 2009 | 269 | 0.070 |
Why?
| | Immunization | 1 | 2008 | 401 | 0.070 |
Why?
| | Lymph Nodes | 1 | 2008 | 423 | 0.070 |
Why?
| | Male | 4 | 2021 | 55554 | 0.070 |
Why?
| | Receptors, Drug | 1 | 2004 | 12 | 0.060 |
Why?
| | Potassium Channels, Inwardly Rectifying | 1 | 2004 | 22 | 0.060 |
Why?
| | Immunoglobulin G | 1 | 2008 | 774 | 0.060 |
Why?
| | Potassium Channels | 1 | 2004 | 121 | 0.060 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2004 | 123 | 0.060 |
Why?
| | Signal Transduction | 2 | 2019 | 4521 | 0.060 |
Why?
| | CX3C Chemokine Receptor 1 | 1 | 2023 | 17 | 0.060 |
Why?
| | Hypertension, Pulmonary | 1 | 2014 | 1728 | 0.050 |
Why?
| | Endothelium | 1 | 2023 | 109 | 0.050 |
Why?
| | Mice, Inbred BALB C | 2 | 2018 | 1151 | 0.050 |
Why?
| | alpha 1-Antitrypsin | 1 | 2023 | 100 | 0.050 |
Why?
| | Wnt Signaling Pathway | 1 | 2023 | 147 | 0.050 |
Why?
| | Cell Communication | 1 | 2023 | 279 | 0.050 |
Why?
| | Ligands | 1 | 2023 | 564 | 0.050 |
Why?
| | beta-N-Acetylhexosaminidases | 1 | 2021 | 9 | 0.050 |
Why?
| | Th1-Th2 Balance | 1 | 2021 | 9 | 0.050 |
Why?
| | Chitinases | 1 | 2021 | 8 | 0.050 |
Why?
| | CD11 Antigens | 1 | 2021 | 30 | 0.050 |
Why?
| | Cell Size | 1 | 2021 | 80 | 0.050 |
Why?
| | Lectins | 1 | 2021 | 43 | 0.050 |
Why?
| | CD11b Antigen | 1 | 2021 | 57 | 0.050 |
Why?
| | Monocytes | 1 | 2023 | 503 | 0.050 |
Why?
| | Quantitative Trait Loci | 1 | 2022 | 307 | 0.050 |
Why?
| | Asthma | 1 | 2012 | 2032 | 0.040 |
Why?
| | Stem Cells | 1 | 2023 | 546 | 0.040 |
Why?
| | Phagocytosis | 1 | 2021 | 350 | 0.040 |
Why?
| | Eosinophils | 1 | 2021 | 278 | 0.040 |
Why?
| | DNA Methylation | 1 | 2022 | 496 | 0.040 |
Why?
| | Endothelial Cells | 1 | 2023 | 681 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2019 | 593 | 0.040 |
Why?
| | RNA | 1 | 2022 | 810 | 0.030 |
Why?
| | DNA | 1 | 2022 | 1351 | 0.030 |
Why?
| | Neutrophils | 1 | 2021 | 1163 | 0.030 |
Why?
| | Female | 2 | 2021 | 59483 | 0.030 |
Why?
| | Sepharose | 1 | 2014 | 31 | 0.030 |
Why?
| | Aging | 1 | 2023 | 1620 | 0.030 |
Why?
| | Glycine | 1 | 2014 | 152 | 0.030 |
Why?
| | Arginine | 1 | 2014 | 236 | 0.030 |
Why?
| | Heparin | 1 | 2014 | 222 | 0.030 |
Why?
| | Doxycycline | 1 | 2012 | 55 | 0.030 |
Why?
| | Osteoarthritis | 1 | 2015 | 171 | 0.030 |
Why?
| | Running | 1 | 2015 | 207 | 0.030 |
Why?
| | Bone and Bones | 1 | 2015 | 278 | 0.020 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2014 | 589 | 0.020 |
Why?
| | Knee Joint | 1 | 2015 | 323 | 0.020 |
Why?
| | Polymorphism, Genetic | 1 | 2015 | 612 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2014 | 728 | 0.020 |
Why?
| | Genotype | 1 | 2014 | 1773 | 0.020 |
Why?
| | Cotinine | 1 | 2009 | 69 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2012 | 1086 | 0.020 |
Why?
| | Time Factors | 1 | 2018 | 6122 | 0.020 |
Why?
| | RNA Interference | 1 | 2009 | 437 | 0.020 |
Why?
| | Nicotine | 1 | 2009 | 265 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2012 | 2196 | 0.020 |
Why?
| | Sulfonylurea Receptors | 1 | 2004 | 4 | 0.020 |
Why?
| | Hydrogen Bonding | 1 | 2004 | 143 | 0.010 |
Why?
| | Protein Structure, Secondary | 1 | 2004 | 325 | 0.010 |
Why?
| | Models, Molecular | 1 | 2004 | 1378 | 0.010 |
Why?
|
|
Gally's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|